BRAIN Biotech AG (XTER:BNN) Other Income (Expense) : €-0.34 Mil (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is BRAIN Biotech AG Other Income (Expense)?

BRAIN Biotech AG's other income expense for the BRAIN Biotech AG's pretax income for the three months ended in Jun. 2024 was €-0.05 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.34 Mil.

BRAIN Biotech AG Other Income (Expense) Historical Data

The historical data trend for BRAIN Biotech AG's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG Other Income (Expense) Chart

BRAIN Biotech AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Income (Expense)

Get a 7-Day Free Trial

-4.92

-1.76

3.71

1.04

-0.99

BRAIN Biotech AG Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Income (Expense)	Get a 7-Day Free Trial															-0.21	-0.18	-0.03	-0.08	-0.05

BRAIN Biotech AG Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.34 Mil.

BRAIN Biotech AG (XTER:BNN) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

BRAIN Biotech AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

0RFI:UK

Address

Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673

Website

https://www.brain-biotech.com

BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.

Executives

Dr. Michael Majerus	Supervisory Board
Dr. Georg Kellinghusen	Supervisory Board
Michael Schneiders	Board of Directors
Adriaan Moelker	Board of Directors
Lukas Linnig	Board of Directors

BRAIN Biotech AG Headlines

No Headlines